Also, quite a few properly set up adverse prognostic markers, such as U-CLL, ATM aberrations or NOTCH1/BIRC3 mutations, missing their damaging outcome in individuals addressed with VO. The only component that remained predictive of a shorter development-no cost survival With this cohort of individuals was TP53 aberrations.112 Eventually, the altern